GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ZSTK · Jun 30, 2025

ZeroStack Corp.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001062993-25-013438General Corporate
Debt relative to revenueRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.debt_to_revenue

20.82% · OPTIONAL · NOT_ENOUGH_HISTORY

Capex intensity70thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.44% · OPTIONAL · VALID

Operating cash generation30thOwn-history percentile · N=10
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-19.52% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

-5.66% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure30thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

32.45% · OPTIONAL · VALID

Gross margin10thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.gross_margin

19.13% · CORE · VALID

Operating margin60thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.operating_margin

-17.34% · CORE · VALID

R&D intensity60thOwn-history percentile · N=10
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

0.49% · OPTIONAL · VALID

SBC intensity30thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1.16% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History15 statesHistory building
Dec 31, 20220/7 normalizedLevel 3Mar 31, 20230/7 normalizedLevel 3Jun 30, 20230/7 normalizedLevel 3Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20247/8 normalizedLevel 3Mar 31, 20257/9 normalizedLevel 3Jun 30, 20257/9 normalizedLevel 3Sep 30, 20256/8 normalizedLevel 3Dec 31, 20257/8 normalizedLevel 3Mar 31, 20267/8 normalizedLevel 3Jun 30, 20267/8 normalizedLevel 3
Period transition

What moved in the state?

Balance Sheet Leverage Decreased
Previous
21.04%
Current
20.82%
Delta
-0.22%
Capex Intensity Increased
Previous
0.20%
Current
0.44%
Delta
0.24%
Cash Generation Increased
Previous
-23.15%
Current
-19.52%
Delta
3.63%
Growth Increased
Previous
-34.63%
Current
-5.66%
Delta
28.98%
Inventory Pressure Decreased
Previous
40.66%
Current
32.45%
Delta
-8.21%
Margin Decreased
Previous
24.50%
Current
19.13%
Delta
-5.38%
Profitability Decreased
Previous
-8.29%
Current
-17.34%
Delta
-9.05%
R And D Intensity Decreased
Previous
0.96%
Current
0.49%
Delta
-0.47%
Sbc Intensity Decreased
Previous
1.46%
Current
1.16%
Delta
-0.30%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · ZSTK Fundamental State →Has State · ZeroStack Corp. →Transitioned To · ZSTK Fundamental State →Transitioned To · ZSTK BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · ZSTK CAPEX_INTENSITY_INCREASED →Transitioned To · ZSTK CASH_GENERATION_INCREASED →Transitioned To · ZSTK GROWTH_INCREASED →Transitioned To · ZSTK INVENTORY_PRESSURE_DECREASED →Transitioned To · ZSTK MARGIN_DECREASED →Transitioned To · ZSTK PROFITABILITY_DECREASED →Transitioned To · ZSTK R_AND_D_INTENSITY_DECREASED →Transitioned To · ZSTK SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.